The Media Database That Really Understands Journalists

Explore Our Database And See What Journalists Create So You Can Better Connect 🫶

Find Out More
Login
Free Trial

Media Database Y yahoo.com FSD Pharma

FSD Pharma
fsdpharma

5447 followers

55 University Ave. Suite 1003

By advancing novel biotechnologies, we are developing hope for a positive tomorrow through our pursuit to achieve Total Brain Health.

Publications:
yahoo.com
Topics
business, cannabis
Recent articles
UNBUZZD™ | FSD Pharma Inc.
Nov 21, 2023
fsdpharma.com
FSD Pharma Signs Definitive Agreement to Launch UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
Aug 02, 2023
finance.yahoo.com
FSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second Cohort
May 11, 2023
fsdpharma.com
FSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second Cohort
May 10, 2023
businesswire.com
FSD Pharma Announces Its Australian Entity Receives Approval to Proceed with Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder
Mar 28, 2023
fsdpharma.com
FSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder
Mar 22, 2023
finance.yahoo.com
FSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder
Mar 22, 2023
businesswire.com
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium
Jul 13, 2022
businesswire.com
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets - CannabisFN
May 10, 2022
cannabisfn.com
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
May 10, 2022
businesswire.com

Find out everything there is to know

Publication resume, most loved topics, and more. Find out everything there is to know about a journalist, in our 500k+ database.

Start a free trial of BuzzSumo.

START YOUR FREE TRIAL

Already registered? Log in to your account